| dc.contributor.author | Soyer, N. | |
| dc.contributor.author | Turgut, M. | |
| dc.contributor.author | Haznedaroglu, I. | |
| dc.contributor.author | Yilmaz, F. | |
| dc.contributor.author | Aydogdu, I. | |
| dc.contributor.author | Pir, A. | |
| dc.contributor.author | Yavasoglu, I. | |
| dc.date.accessioned | 2020-06-21T13:18:05Z | |
| dc.date.available | 2020-06-21T13:18:05Z | |
| dc.date.issued | 2017 | |
| dc.identifier.issn | 0145-2126 | |
| dc.identifier.issn | 1873-5835 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12712/12195 | |
| dc.description | 8th International Eurasian Hematology Oncology Congress (EHOC) -- OCT 18-21, 2017 -- Istanbul, TURKEY | en_US |
| dc.description | Karakus, Volkan/0000-0001-9178-2850; Haznedaroglu, Ibrahim C./0000-0001-8028-9462 | en_US |
| dc.description | WOS: 000416742600048 | en_US |
| dc.description.abstract | … | en_US |
| dc.language.iso | eng | en_US |
| dc.publisher | Pergamon-Elsevier Science Ltd | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.title | Efficacy and Safety of Ruxolitinib in Turkish Patients With Chronic Myeloproliferative Neoplasms: A Multicenter and Retrospective Analysis | en_US |
| dc.type | conferenceObject | en_US |
| dc.contributor.department | OMÜ | en_US |
| dc.identifier.volume | 61 | en_US |
| dc.identifier.startpage | S19 | en_US |
| dc.identifier.endpage | S19 | en_US |
| dc.relation.journal | Leukemia Research | en_US |
| dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
